Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Antibody & Protein Engineering
Is Your WASH Causing Inflammation? Protein Complex Linked to Inflammatory Conditions
Research published by the Scripps Research Institute reveals the WASH protein complex as a crucial factor in neutrophil-triggered inflammation.
Why We Develop Autoimmunity: Hyperstimulation of Genetically Prone Subjects
Professor Yehuda Shoenfeld explains his findings in establishing links between genetic predisposition and hyperstimulation of the immune system and how this may help us better understand the development of autoimmunity.
Advanced Vaccine Platforms & Technologies
Wieslaw Swietnicki, Head of Biosynthesis and Bioengineering Group at the Institute of Industrial Organic Chemistry, leads a discussion on the current outlook for advanced vaccine platforms, technologies, and development.
Drug Discovery & Development
The Challenges Facing Antibody-Drug Conjugates for Immuno-Oncology
The targeted cancer therapy has made recent clinical and market breakthroughs, but what are the next hurdles for ADCs?
Pfizer’s Pneumococcal Vaccine Shows Great Promise in European Study
Pfizer’s new PCV candidate is set to become the most effective protector against pneumococcal infections for infants.
Peptide Chemistry
FDA Gives Green Light to Long-Awaited Botox Competitor
Competition between cosmetic treatments begins.
